Zusammenfassung
Mit Typ II-Hyperlipoproteinämie [1] wird eine Vermehrung der Serum-β-LP bezeichnet. Serum-Cholesterin und -Phospholipide sind deutlich erhöht, entsprechend dem sehr geringen Gehalt der β-LP die Serumtriglyceride nur minimal.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Altschul, R., Hoffer, A., Steben, J. D.: Influence of nicotinic acid on serum cholesterol in man. Arch. Biochem. Biophys. 54, 558 (1955).
Casdorph, H. R.: Cholestyramine therapy of hypercholesterolemia Progress in Biochemical Pharmacology, Vol. 2. Ed. Kritchevsky, D., Paoletti, R., Steinberg, D., Basel-New York: Karger, 1967, p. 448.
Cronheim, G. E.: Heparin, Heparinoids, and the clearing factor. Lipid Pharmacology. Ed. R. Paoletti. New York-London: Academic Press, 1964, p. 381.
Fredrickson, D. S., Levy, R.I., Jones, Edith, Bonnell, Merme, Ernst, Nancy: Dietary management of hyperlipoproteinemia. Nat. Heart and Lung Inst., Bethesda, Maryland, USA, 1970.
Furman, R.H., Robinson Jr., C.W.: Hypocholesterolemic agents. Med. Clin. N. Amer. 45, 935 (1961).
Kinsell, L. W., Schliert, G., Kahlke, W., Schettler, G.: Essential Hyperlipemia. Lipids and Lipidoses. Ed. G. Schettler. Berlin-Heidelberg-New York: Springer, 1967, p. 446.
Miller, O. N., Hamilton, J. G.: Nicotinic acid and its derivatives. Lipid Pharmacology, Ed. R. Paoletti. New York-London: Academic Press, 1964, p. 275.
Myant, N.B.: The thyroid and lipid metabolism. Lipid Pharmacology. Ed. R. Paoletti, New York-London: Academic Press, 1964, p. 299.
Oliver, M. F.: Hormones. Atherosclerosis. Ed. F. G. Schettler and G. S. Boyd. Amsterdam-London-New York: Elsevier Publishing Company, 1969, p. 865.
Sanwald, R.: Nicotinic acid. Atherosclerosis. Ed. F. G. Schettler and G. S. Boyd. Amsterdam-London-New York: Elsevier Publishing Company, 1969, p. 901.
Schettler, F. G.: Surface-active substances. Atherosclerosis. Ed. F. G. Schettler and G. S. Boyd. Amsterdam-London-New York: Elsevier Publishing Company, 1969, p. 883.
Schettler, G., Kahlke, W., Schlierf, G.: Essential hypercholesterolemia. Lipids and Lipidoses. Ed. G. Schettler. Berlin-Heidelberg-New York: Springer, 1967, p. 412.
Schoch, H. K.: The U.S. Veterans Administration Cardiology Drug — Lipid Study: An Interim Report. Advances in Experimental Medicine and Biology, Vol. 4. Eds.: E. L. Holmes, L. A. Carlson, and R. Paoletti. New York: Plenum Press, 1969, p. 405.
Zöllner, N., Gudenzi, M.: Behandlung der Hypercholesterinämie mit β-Pyridylcarbinol. Med. Klin. 61, 1996 (1966).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Sanbar, S.S. (1972). Familiäre Hyperlipoproteinämie vom Typ II. In: Schwandt, P. (eds) Risikofaktor Hyperlipidämie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95218-0_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-95218-0_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-05610-2
Online ISBN: 978-3-642-95218-0
eBook Packages: Springer Book Archive